Keyword: R&D

News

Aerie and DSM in Eye Diseases Pact

10.08.2017 - US clinical stage pharmaceutical company Aerie Pharmaceuticals has entered into a research, development and license agreement with Dutch life sciences group DSM. The agreement...

News

Sanofi and Ablynx Link on Nanobody Therapeutics

04.08.2017 - French drugmaker Sanofi has signed a research and licensing deal with Belgian biopharmaceutical company Ablynx, initially focusing on the development and commercialization of...

News

Advanced Enzyme Technologies Buys Evoxx

03.08.2017 - Indian enzyme manufacturer Advanced Enzyme Technologies has announced it will acquire all of German industrial biotech company Evoxx Technologies for €7.65 million in a bid to...

News

Merck KGaA Opens Applications Lab in Shanghai

01.08.2017 - German pharmaceuticals, chemicals and life sciences group Merck has opened a new application laboratory for its Performance Materials business sector in Shanghai, China. The...

News

Eli Lilly and Nektar Develop Autoimmune Therapy

31.07.2017 - US pharma companies Eli Lilly and Nektar Therapeutics have signed an agreement to jointly develop the latter’s novel immunotherapy, NKTR-358, which could potentially treat a number...

News

FDA Approves New Breast Cancer Treatment

19.07.2017 - The US Food and Drug Administration (FDA) has approved Nerlynx (neratinib), made by Puma Biotechnology for the extended adjuvant treatment of early-stage, HER2-positive breast...

News

Celgene to Buy into China’s BeiGene

13.07.2017 - US biopharmaceutical company Celgene has agreed to buy a stake in China’s BeiGene and help to develop and commercialize that company’s investigational treatment for tumor cancers...

News

Merck KGaA and iOnctura in new JV

05.07.2017 - Merck Ventures, the strategic investment arm of German pharmaceuticals and life sciences group Merck KGaA, has created immuno-oncology company iOnctura. Based in Geneva...